在产前晚期早产类固醇后新生儿低血糖症
Alison Asirwatham1, Rohini Loke2, Sophia Rose2
1Maternal-Fetal Medicine Fellow, UMass Chan Medical School, Worcester, Massachusetts.
American journal of perinatology
|August 4, 2025
概括
产前晚期早产类固醇 (ALPS) 可以增加新生儿低血糖症的风险,特别是当分娩发生在甲 (BMZ) 暴露后12-35小时时时. 这一时机对于接受类固醇的晚期早产婴儿的风险管理至关重要.
科学领域:
- 新生儿医学 新生儿医学
- 产科 产科 产科 产科 产科
- 药理学 药理学是指药理学的学科.
背景情况:
- 晚期早产婴儿面临较高的发病风险,与期满婴儿相比.
- 贝塔米他 (BMZ) 减少呼吸困难,但可能导致新生儿低血糖症.
- 产前晚期早产类固醇 (ALPS) 用于减轻晚期早产婴儿的风险.
研究的目的:
- 为了确定ALPS管理后新生儿低血糖症的临床风险因素.
- 评估与部分ALPS课程相关的结果.
- 提供有关ALPS使用和新生儿护理的临床决策信息.
主要方法:
- 对239名怀孕患者进行了回顾性研究,这些患者在怀孕34-36周之间分娩.
- 纳入标准:接受了1-2剂ALPS;排除标准:之前的BMZ,孕期糖尿病,胎儿异常,多胎妊娠.
- 新生儿低血糖症定义为<30 mg/dL (前24小时) 和<45 mg/dL (24小时后).
主要成果:
- 低血糖的发生率随着母亲的年龄,剖腹产和分娩开始而增加.
- 在BMZ后48小时的分娩与较高的低血糖和NICU入院率有关.
- 在第一次BMZ剂量后12-35小时观察到最大的低血糖风险.
结论:
- 部分ALPS疗程与新生儿低血糖和NICU入院的增加有关.
- 与BMZ施用相对的分娩时间是新生儿结果的关键因素.
- 了解这些风险有助于优化ALPS的使用和晚期早产儿的产后护理.
相关概念视频
Hypoglycemia and Glucagon
337
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
337
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Teratogenicity
2.8K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.8K


